Could an immune booster help colorectal cancer patients live longer?
NCT ID NCT06557668
First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 13 times
Summary
This study looks at whether adding an immunomodulator (a drug that helps the immune system) to standard cancer treatments can improve survival for people with colorectal cancer. Researchers will review medical records of 250 adults who started treatment between 2020 and 2024. The goal is to see if the combination therapy leads to better overall survival and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Chung-Shan Medical University Hospital
NOT_YET_RECRUITINGTaichung, Taiwan
-
Taichung Veterans General Hospital
RECRUITINGTaichung, Taiwan
Conditions
Explore the condition pages connected to this study.